Morgan Stanley Expansion Capital (“Expansion Capital”) invests in later-stage, private emerging growth companies in technology and other high growth sectors including healthcare, consumer and digital media. Our investment team brings a depth of experience partnering with entrepreneurial management teams to help develop and scale their businesses as well as leveraging the Morgan Stanley network to benefit our portfolio.
Morgan Stanley has a long and successful history growth investing. Since 1986, Expansion Capital and its predecessor, Morgan Stanley Venture Partners, have invested over $1.1 billion of growth capital in over 150 companies. While we are fully integrated into Morgan Stanley’s global financial services network, we operate independently within the Firm. Our team works closely with its limited partner base of successful entrepreneurs and business professionals to assist in building proprietary advantage for our companies.
|NanoString Technologies||12/2012||Series E||$15.3M||7|
|Clinipace WorldWide||9/2011||Series C||$15M||4|